Skip to content
Screener

Rogers Corporation ROG Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

3M logo
3MMMM
$62M-25.3%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$323.51M
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$713K-92.3%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$84M+2,000%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$471K
Entegris logo
EntegrisENTG
$14.3M+921%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.36B+87.0%
Enterprise value$2.21B+93.9%
P/E88.5×
P/S2.8×+1.2×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.

The source filing: Rogers Corporation’s 10-K, filed February 19, 2026.

Filed
Feb 19, 2026, 2:35 PM EST
Fiscal year
FY2025
Accession
0000084748-26-000007
(Dollars in millions)202520242023
Repayment of debt principal and finance lease obligations(1.3)(30.4)(185.4)
Line of credit issuance costs(1.7)
Payments of taxes related to net share settlement of equity awards(1.4)(1.4)(3.2)
Proceeds from issuance of shares to employee stock purchase plan1.21.5
Share repurchases(52.4)(19.8)
Net cash used in financing activities(53.9)(50.1)(190.3)
Effect of exchange rate fluctuations on cash4.7(3.3)2.6
Net increase (decrease) in cash and cash equivalents37.228.1(104.2)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Rogers Corporation's stock issuance proceeds?
Rogers Corporation (ROG) reported stock issuance proceeds of $500K in Q4 2025.
How has Rogers Corporation's stock issuance proceeds changed year-over-year?
Rogers Corporation's stock issuance proceeds decreased by 16.7% year-over-year, from $600K to $500K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Rogers Corporation's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude